Veracyte | VCYT - Trade Debtors


Veracyte reported $54.18M in Trade Debtors for its fiscal quarter ending in June of 2026.





Trade Debtors Change Date
Agenus USD 22.34M 107K Mar/2026
Agilent USD 1.5B 23M Mar/2026
Anika Therapeutics USD 29.33M 661K Dec/2025
Arrowhead Research USD 15.68M 203.19M Mar/2026
Bruker USD 545.9M 3.2M Jun/2026
Heron Therapeutics USD 89.59M 8.54M Dec/2025
Illumina USD 764M 26M Jun/2026
Intrexon USD 1.02M 559K Jun/2024
Karyopharm Therapeutics USD 23.36M 2.82M Mar/2026
Laboratory Of America USD 2.5B 54.3M Jun/2026
Ligand Pharmaceuticals USD 54.8M 6.25M Mar/2026
Myriad Genetics USD 115.3M 2.7M Dec/2025
Rigel Pharmaceuticals USD 28.9M 1.39M Jun/2024
Roche Holding CHF 13.34B 1.44B Jun/2026
Sangamo BioSciences USD 581K 110K Jun/2024
Siemens EUR 28.59B 484M Jun/2026
Sonic Healthcare AUD 1.39B 23.76M Dec/2024
Thermo Fisher Scientific USD 9.45B 247M Jun/2026
Veracyte USD 54.18M 4.06M Jun/2026
Waters USD 1.99B 228M Jun/2026